As the HIV research community prepares to convene for the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 ...

This episode, titled Positioning Emerging Targeted Therapies in the Evolving IgA Nephropathy Treatment Paradigm, features ...

In the final episode, Assessing Long-Term Renal Outcomes and Kidney Failure Risk Reduction in IgA Nephropathy, the panelists ...

A US-focused cohort study published in 2023 showed similar trends, with a higher AA incidence observed among women (range, ...

From clinic closures to gene therapy costs, new data reveal how policy, prices, and structural racism reshape US health ...

City leaders share real-world GLP-1 coverage tactics, showing how public employers balance access, costs, and lasting ...

Oral Wegovy reshapes GLP-1 costs: cash pay can be cheaper, insurance pricing often matches shots, and coverage hinges on employer benefits and coding.

This move is another step in Makary’s attempts to shorten FDA reviews, which started when he began his tenure last year. 3 These include mandating the use of artificial intelligence for staffers and ...

Compensation reforms prohibit price- or rebate-linked PBM revenue in Part D, pushing flat service-fee models and broadly capturing affiliates such as rebate GPOs and aggregators. Reform priorities aim ...

Chomont is a Professor in the Department of Microbiology, Infectious Diseases, and Immunology at the Université de Montréal and a researcher at the CHUM Research Centre CROI 2026 highlights will ...

Emerging HER2-targeted therapies in lung cancer highlight the importance of real-world data and survival metrics for patient ...

In an interview with The American Journal of Managed Care®, Levin explained that for patients whose medications are covered ...